BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36768835)

  • 21. Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg.
    Roebuck AJ; Greba Q; Onofrychuk TJ; McElroy DL; Sandini TM; Zagzoog A; Simone J; Cain SM; Snutch TP; Laprairie RB; Howland JG
    Eur J Neurosci; 2022 Feb; 55(4):1063-1078. PubMed ID: 33370468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
    Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portable biosensors for rapid on-site determination of cannabinoids in cannabis, a review.
    Harpaz D; Bernstein N; Namdar D; Eltzov E
    Biotechnol Adv; 2022 Dec; 61():108031. PubMed ID: 36058440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
    Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
    Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond THC and Endocannabinoids.
    Pacher P; Kogan NM; Mechoulam R
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
    Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
    Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Strategies for Rare Cannabinoids Derived from
    Nguyen GN; Jordan EN; Kayser O
    J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Action and Pharmacokinetics of Cannabis.
    Chayasirisobhon S
    Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytochemical characterization and biological properties of two standardized extracts from a non-psychotropic Cannabis sativa L. cannabidiol (CBD)-chemotype.
    Muscarà C; Smeriglio A; Trombetta D; Mandalari G; La Camera E; Grassi G; Circosta C
    Phytother Res; 2021 Sep; 35(9):5269-5281. PubMed ID: 34173287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
    Welling MT; Deseo MA; Bacic A; Doblin MS
    Phytochemistry; 2022 Sep; 201():113282. PubMed ID: 35718133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview.
    Kennedy M
    Intern Med J; 2022 Sep; 52(9):1471-1477. PubMed ID: 35191178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.